Patent · US Active

Articles of manufacture and methods for treatment using adoptive cell therapy

US11944647B2 · kind B2 · utility

2Cited by
94References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2022
Grant dateApr 2, 2024
Priority date
Expiry dateJun 22, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are adoptive cell therapy methods involving the administration of doses of cells for treating disease and conditions, including certain B cell malignancies. The cells generally express recombinant receptors such as chimeric antigen receptors (CARs). In some embodiments, the methods are for treating subjects with non-Hodgkin lymphoma (NHL). In some embodiments, the methods are for treating subjects with relapsed or refractory NHL. Also provided are articles of manufacture and prophylactic treatments in connection with adoptive therapy methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.